CenterBook Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,380
Closed -$752K 846
2026
Q1
$752K Buy
+6,380
New +$891K 0.04% 400
2025
Q4
Sell
-17,672
Closed -$2.36M 666
2025
Q3
$2.36M Buy
+17,672
New +$2.15M 0.12% 236
2023
Q3
Sell
-9,397
Closed -$1.33M 488
2023
Q2
$1.33M Buy
+9,397
New +$1.51M 0.17% 208

Other funds holding RGEN

CenterBook Partners's RGEN Position: Q2 2026 in Review

CenterBook Partners sold out of Repligen (RGEN) in Q2 2026, closing a stake of 6,380 shares — an estimated $752K sold.

CenterBook Partners first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $2.36M in Q3 2025. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • CenterBook Partners reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • CenterBook Partners sold 6,380 Repligen shares in Q2 2026, an estimated $752K.
  • CenterBook Partners first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
  • CenterBook Partners's Repligen position peaked at $2.36M in Q3 2025.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.